Phosphotungstic acid hematoxylin

Jump to navigation Jump to search

WikiDoc Resources for Phosphotungstic acid hematoxylin

Articles

Most recent articles on Phosphotungstic acid hematoxylin

Most cited articles on Phosphotungstic acid hematoxylin

Review articles on Phosphotungstic acid hematoxylin

Articles on Phosphotungstic acid hematoxylin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Phosphotungstic acid hematoxylin

Images of Phosphotungstic acid hematoxylin

Photos of Phosphotungstic acid hematoxylin

Podcasts & MP3s on Phosphotungstic acid hematoxylin

Videos on Phosphotungstic acid hematoxylin

Evidence Based Medicine

Cochrane Collaboration on Phosphotungstic acid hematoxylin

Bandolier on Phosphotungstic acid hematoxylin

TRIP on Phosphotungstic acid hematoxylin

Clinical Trials

Ongoing Trials on Phosphotungstic acid hematoxylin at Clinical Trials.gov

Trial results on Phosphotungstic acid hematoxylin

Clinical Trials on Phosphotungstic acid hematoxylin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Phosphotungstic acid hematoxylin

NICE Guidance on Phosphotungstic acid hematoxylin

NHS PRODIGY Guidance

FDA on Phosphotungstic acid hematoxylin

CDC on Phosphotungstic acid hematoxylin

Books

Books on Phosphotungstic acid hematoxylin

News

Phosphotungstic acid hematoxylin in the news

Be alerted to news on Phosphotungstic acid hematoxylin

News trends on Phosphotungstic acid hematoxylin

Commentary

Blogs on Phosphotungstic acid hematoxylin

Definitions

Definitions of Phosphotungstic acid hematoxylin

Patient Resources / Community

Patient resources on Phosphotungstic acid hematoxylin

Discussion groups on Phosphotungstic acid hematoxylin

Patient Handouts on Phosphotungstic acid hematoxylin

Directions to Hospitals Treating Phosphotungstic acid hematoxylin

Risk calculators and risk factors for Phosphotungstic acid hematoxylin

Healthcare Provider Resources

Symptoms of Phosphotungstic acid hematoxylin

Causes & Risk Factors for Phosphotungstic acid hematoxylin

Diagnostic studies for Phosphotungstic acid hematoxylin

Treatment of Phosphotungstic acid hematoxylin

Continuing Medical Education (CME)

CME Programs on Phosphotungstic acid hematoxylin

International

Phosphotungstic acid hematoxylin en Espanol

Phosphotungstic acid hematoxylin en Francais

Business

Phosphotungstic acid hematoxylin in the Marketplace

Patents on Phosphotungstic acid hematoxylin

Experimental / Informatics

List of terms related to Phosphotungstic acid hematoxylin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Phosphotungstic acid haematoxylin (PTAH) is a mix of haematoxylin with phosphotungstic acid, used in histology for staining. It stains some tissue in contrasting colors in a way similar to haematoxylin and eosin stain, as phosphotungstic acid binds to tissue proteins. It is used to show gliosis in the central nervous system, tumours of skeletal muscles, and fibrin deposits in lesions. Muscle is stained blue-black to dark brown, connective tissue is pale orange-pink to brownish red, fibrin and neuroglia stain deep blue, coarse elastic fibers show as purple, and bone and cartilage obtain yellowish to brownish red color. PTAH is ideal for demonstrating striated muscle fibers and mitochondria, often without a counterstain.

PTAH stains ependymomas while it does not stain choroid plexus papillomas, providing one means of differentiating these tumors.

Template:SIB Template:WH Template:WS